Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Localised axial progenitor cell populations in the avian tail bud are not committed to a posterior Hox identity.

McGrew MJ, Sherman A, Lillico SG, Ellard FM, Radcliffe PA, Gilhooley HJ, Mitrophanous KA, Cambray N, Wilson V, Sang H.

Development. 2008 Jul;135(13):2289-99. doi: 10.1242/dev.022020. Epub 2008 May 28.

2.

Efficient generation of transgenic pigs using equine infectious anaemia virus (EIAV) derived vector.

Whitelaw CB, Radcliffe PA, Ritchie WA, Carlisle A, Ellard FM, Pena RN, Rowe J, Clark AJ, King TJ, Mitrophanous KA.

FEBS Lett. 2004 Jul 30;571(1-3):233-6.

3.

Efficient production of germline transgenic chickens using lentiviral vectors.

McGrew MJ, Sherman A, Ellard FM, Lillico SG, Gilhooley HJ, Kingsman AJ, Mitrophanous KA, Sang H.

EMBO Rep. 2004 Jul;5(7):728-33. Epub 2004 Jun 11.

4.

Highly efficient EIAV-mediated in utero gene transfer and expression in the major muscle groups affected by Duchenne muscular dystrophy.

Gregory LG, Waddington SN, Holder MV, Mitrophanous KA, Buckley SM, Mosley KL, Bigger BW, Ellard FM, Walmsley LE, Lawrence L, Al-Allaf F, Kingsman S, Coutelle C, Themis M.

Gene Ther. 2004 Jul;11(14):1117-25.

PMID:
15141156
5.

Long-term transgene expression by administration of a lentivirus-based vector to the fetal circulation of immuno-competent mice.

Waddington SN, Mitrophanous KA, Ellard FM, Buckley SM, Nivsarkar M, Lawrence L, Cook HT, Al-Allaf F, Bigger B, Kingsman SM, Coutelle C, Themis M.

Gene Ther. 2003 Aug;10(15):1234-40.

PMID:
12858188
6.

Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors.

Rohll JB, Mitrophanous KA, Martin-Rendon E, Ellard FM, Radcliffe PA, Mazarakis ND, Kingsman SM.

Methods Enzymol. 2002;346:466-500. No abstract available.

PMID:
11883086
7.

Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery.

Mazarakis ND, Azzouz M, Rohll JB, Ellard FM, Wilkes FJ, Olsen AL, Carter EE, Barber RD, Baban DF, Kingsman SM, Kingsman AJ, O'Malley K, Mitrophanous KA.

Hum Mol Genet. 2001 Sep 15;10(19):2109-21.

PMID:
11590128
8.

Evidence for the role of His-142 of protein 1C in the acid-induced disassembly of foot-and-mouth disease virus capsids.

Ellard FM, Drew J, Blakemore WE, Stuart DI, King AM.

J Gen Virol. 1999 Aug;80 ( Pt 8):1911-8.

PMID:
10466786
9.

The structure and function of a foot-and-mouth disease virus-oligosaccharide receptor complex.

Fry EE, Lea SM, Jackson T, Newman JW, Ellard FM, Blakemore WE, Abu-Ghazaleh R, Samuel A, King AM, Stuart DI.

EMBO J. 1999 Feb 1;18(3):543-54.

10.

Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin alpha(v)beta3 in vitro.

Jackson T, Sharma A, Ghazaleh RA, Blakemore WE, Ellard FM, Simmons DL, Newman JW, Stuart DI, King AM.

J Virol. 1997 Nov;71(11):8357-61.

11.

Efficient infection of cells in culture by type O foot-and-mouth disease virus requires binding to cell surface heparan sulfate.

Jackson T, Ellard FM, Ghazaleh RA, Brookes SM, Blakemore WE, Corteyn AH, Stuart DI, Newman JW, King AM.

J Virol. 1996 Aug;70(8):5282-7.

12.

Supplemental Content

Loading ...
Support Center